NOVO NORDISK'S RETATRUTIDE: A NEW SOLUTION FOR WEIGHT CONTROL?

Recent clinical information suggests that Novera Retatrutide, a dual-action therapy from Novo Nordisk, could provide a meaningful breakthrough in body loss. Unlike many existing treatments, Retatrutide impacts both glucagon-like peptide-1 (GLP-1) and the GIP hormone, potentially resulting to impr